Early Career Awards
The Society encourages and recognizes outstanding work by young investigators. Trainee achievement is recognized by the annual presentation of the Lee B. Lusted Student Prizes for outstanding presentations of research at the Annual Meeting. The Young Investigator Award is presented annually for the best paper published by a trainee or junior faculty member.
The Young Investigator Award is presented annually for the best paper published by a trainee or junior faculty member.
2019 - Hawre Jalal, MD, PhD
Jalal H, Buchanich J, Roberts M, Balmert L, Zhang K, Burke D. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 361, 1218 (2018) 21 September. doi: 10.1126/science.aau1184.
2018 - Jarrod Dalton, PhD
Dalton JE, Perzynski AT, Zidar DA, Rothberg MB, Coulton CJ, Milinovich AT, et al. Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position: A Retrospective Cohort Study. Ann Intern Med. 2017;167:456–464. doi: 10.7326/M16-2543
2017 (co-recipient) - Phuc Le, PhD
Phuc Le, PhD, MPH; Michael Rothberg, MD, MPH. Determining the Optimal Vaccination Schedule for Herpes Zoster: A Cost-Effectiveness Analysis. Journal of General Internal Medicine 2016.
2017 (co-recipient) - Ellen G. Engelhardt, PhD
Ellen G. Engelhardt, Arwen H. Pieterse, Anja van der Hout, Hanneke J.C.J.M. de Haes, Judith R. Kroep, Patricia Quarles van Ufford-Mannesse, Johanneke E.A. Portielje, Ellen M.A. Smets, Anne M. Stiggelbout. Use of Implicit Persuasion in Decision Making About Adjuvant Cancer Treatment: A Potential Barrier to Shared Decision Making. European Journal of Cancer 2016.
2016 - Ankur Pandya, PhD
Ankur Pandya, PhD; Stephen Sy, MS; Sylvia Cho, MHS; Milton C. Weinstein, PhD; Thomas A. Gaziano, MD, MSc. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. JAMA 2015; 314(2):142-150.
2015 - Joshua A. Roth, PhD, MHA
Joshua A. Roth, PhD, MHA; Ruth Etzioni, PhD; Teresa M. Waters, PhD; Mary Pettinger, MS; Jacques E. Rossouw, MD; Garnet L. Anderson, PhD; Rowan T. Chlebowski, MD, PhD; JoAnn E. Manson, MD, DrPH; Mark Hlatky, MD; Karen C. Johnson, MD, MPH; and Scott D. Ramsey, MD, PhD. Economic Return From the Women’s Health Initiative Estrogen Plus Progestin Clinical Trial: A Modeling Study. Annals of Internal Medicine. 2014;160(9):594-602.
2014 - Glen Taksler, PhD
Taksler, Glen B., PhD, Melanie Keshner, MSN, FNP, Angela Fagerlin, PhD, Negin Hajizadeh, MD, MPH, and R. Scott Braithwaite, MD, MSc. Personalized Estimates of Benefit From Preventive Care Guidelines: A Proof of Concept. Annals of Internal Medicine 159.3 (2013): 161-69.
2013 – Tessa Genders, PhD
Genders TS, Steyerberg EW, Hunink MG for the CAD consortium. Prediction model to estimate presence of coronary artery disease: retrospective pooled analysis of existing cohorts. BMJ. 2012 Jun 12;344:e3485
2012 – Ashleigh R. Tuite, MSc, MPH
Cholera Epidemic in Haiti, 2010: Using a Transmission Model to Explain Spatial Spread of Disease and Identify Optimal Control Interventions. Ann Intern Med. 2011;154:593-601
2011 – Claire McKenna, PhD
Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions. McKenna C, Chalabib Z, Epstein D, Claxton K. Journal of Health Economics 2010; 29:170-181.
2010 – Angelo Volandes, MD
Video Decision Support Tool for Advance Care Planning in Dementia: Randomized Controlled Trial. British Medical Journal in 2009 (BMJ. 2009 May 28;338:b2159. doi: 10.1136/bmj.b2159.
2009 – Heather Taffet Gold, PhD
Correlates and Effect of Suboptimal Radiotherapy in Women With Ductal Carcinoma in Situ or Early Invasive Breast Cancer. Gold HT, Do HT, Dick AW. Cancer 2008; 113(11): 3108-3115.
2008 – Jennifer L. Bailit
Bailit JL, Votruba ME: Medical cost savings associated with 17 alpha hydroxyprogesterone caproate. Am J Obstet Gynecol 2007;196:219.e1-219.e7.
2007 – Andrea Gurmankin, PhD, MBe
Gurmankin A, Micco E, Putt M, Armstrong K: Value for the future and breast cancer-preventive health behavior
2006 – Allison Rosen, MD, MPH, ScD
Rosen AB, Hamel MB, Weinstein MC, Cutler DM, Fendrick AM, Vijan S: Cost-effectiveness of full Medicare coverage of Angiotensin-Converting Enzye Inhibitors for beneficiaries with diabetes. Ann Intern Med. 2005; 143: 89-99.
2005 – Angela Fagerlin, PhD
Fagerlin A, Schneider C: Enough: the failure of the living will. Hastings Center Report 2004 (2): 30-42.
2004 – Ida Sim, MD PhD
Sim I, Cummings S: A new framework for describing and quantifying the gap between proof and practice. Medical Care 2003; 41: 874-881.
2003 – Alan Schwartz, PhD
Schwartz A, Hasnain M: Risk perception and risk attitude in informed consent. Risk, Decision and Policy 2002; 7: 121-130.
2002 – Sue Goldie, MD, MPH
Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC: Policy analysis of cervical cancer screening strategies in low resource settings: clinical benefits and cost-effectiveness analysis.
2001 – Gillian D. Sanders, PhD
Sanders GD, Nease RF, Owens DK: Design and Pilot Evaluation of a System to Develop Computer-Based Site-Specific Practice Guidelines from a Decision Model. Medical Decision Making. 2000; 20:145-159.
2000 – Gretchen Chapman, PhD
Chapman GB, Nelson R, Hier DB: Familiarity and Time Preferences: Decision Making About Treatments for Migraine Headaches and Crohn's Disease. Journal of Experimental Psychology. 1999; 5:17-34.
1999 – Aaron Stinnett
Stinnett AA, Mullahy J: Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis, Medical Decision Making. 1998; 18 (Suppl.):S68-S80.
The Lee B. Lusted Student Prizes for outstanding presentations of research at an SMDM Meeting.
Become a Member
SMDM members contribute critically to health policy research in the areas of evidence-based medicine, cost effective health care, patient decision making and public health. SMDM helps you to be more than just a face in the crowd. The connections you make through SMDM can help you build a network of long-term contacts to help you throughout your career.
MDM offers rigorous and systematic approaches to decision making that are designed to improve the health and clinical care of individuals and to assist with health policy development.